These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25140562)

  • 1. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases.
    Momose T; Nariai T; Kawabe T; Inaji M; Tanaka Y; Watanabe S; Maehara T; Oda K; Ishii K; Ishiwata K; Yamamoto M
    Clin Nucl Med; 2014 Nov; 39(11):939-43. PubMed ID: 25140562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
    Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
    Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
    Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
    J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
    Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
    AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.
    Miwa K; Matsuo M; Ogawa S; Shinoda J; Yokoyama K; Yamada J; Yano H; Iwama T
    Radiat Oncol; 2014 Aug; 9():181. PubMed ID: 25123357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery.
    Rava P; Leonard K; Sioshansi S; Curran B; Wazer DE; Cosgrove GR; Norén G; Hepel JT
    J Neurosurg; 2013 Aug; 119(2):457-62. PubMed ID: 23662828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of [¹¹C]methionine PET for stereotactic radiation therapy with intensity modulated radiation therapy to metastatic brain tumors.
    Miwa K; Matsuo M; Shinoda J; Aki T; Yonezawa S; Ito T; Asano Y; Yamada M; Yokoyama K; Yamada J; Yano H; Iwama T
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1139-44. PubMed ID: 22520479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
    Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
    J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases?
    Chang WS; Kim HY; Chang JW; Park YG; Chang JH
    J Neurosurg; 2010 Dec; 113 Suppl():73-8. PubMed ID: 21121789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Astner ST; Adam M; Krause BJ; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):339-44. PubMed ID: 16765533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully automatic approach for multimodal PET and MR image segmentation in gamma knife treatment planning.
    Rundo L; Stefano A; Militello C; Russo G; Sabini MG; D'Arrigo C; Marletta F; Ippolito M; Mauri G; Vitabile S; Gilardi MC
    Comput Methods Programs Biomed; 2017 Jun; 144():77-96. PubMed ID: 28495008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among
    Tomura N; Kokubun M; Saginoya T; Mizuno Y; Kikuchi Y
    AJNR Am J Neuroradiol; 2017 Aug; 38(8):1520-1527. PubMed ID: 28619837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.